233 results
Page 5 of 12
POS AM
ryycb
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
aq8w7p d7rac3qbf3
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
6-K
EX-99
fu2mh o2mfu
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B3
ytfmoe1ntd2o
2 Jul 20
Prospectus supplement
4:28pm
F-1
uzuoxau7i84niyoq
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
9izbq kyfi42ao3hem
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
5r84l1ih wivl3ik9p
3 Jun 20
Current report (foreign)
8:30am
424B5
b2gh8fmcpcf102qgl
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
h6om83d
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
76ezro 0d4mjtn
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
elekrjt0yt4rxg
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
4s9b56blt0qj4x4kee
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
4r994
30 Jan 20
Extraordinary General Meeting of Shareholders
7:00am
6-K
EX-99
3xm91x8n
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-3
0fhzwizq4qof4omw
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-1
oqv 00r7m0fbqh
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
albam rp4
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
sve9yq0m
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am